Cellular Nanoparticle (CNP) Technology

Cellics Therapeutics nanoplatforms offer
an innovative therapeutic approach for complex diseases.

The Cellular Nanoparticle (CNP) redefines the role cells play in our bodies. Cellics' dynamic nanoplatforms leverage the power of cell membranes to craft specialized nanoparticles. Derived from a variety of wild type or engineered human cells, the CNP technology can improve therapeutic effectiveness and overcome drug delivery challenges. 

Cellular Nanosponge (NS) platform: The CNP technology alone can create Cellular Nanosponges, which leverage surface protein receptors on the cell membranes to absorb and neutralize toxins, inflammatory cytokines, and viruses that attack human cells.  

Cellular Nanoparticle (CNP) drug delivery platform: Loading drugs into its nanoparticle core, the CNP technology can significantly improve targeted and intracellular delivery, extend circulation half-life and increase overall delivery efficiency for mRNA, siRNA, proteins, and small molecules.